All Pharma News
Endeavor links IPF drug to improved lung function in phase 2

Endeavor links IPF drug to improved lung function in phase 2
Nick Paul Taylor FIERCE BIOTECH
20 May 2024
Share Share
ENV-101 Phase 2a Shows Lung Function, Fibrosis Reversal In IPF

ENV-101 Phase 2a Shows Lung Function, Fibrosis Reversal In IPF
BUSINESSWIRE
19 May 2024
Share Share
Endeavor: ENV-101 Phase 2a Data At ATS 2024

Endeavor: ENV-101 Phase 2a Data At ATS 2024
BUSINESSWIRE
01 May 2024
Share Share
Endeavor raises $132.5m for fibrosis, cancer drugs

Endeavor raises $132.5m for fibrosis, cancer drugs
Phil Taylor PHARMAPHORUM
24 Apr 2024
Share Share
Endeavor Appoints Chris Krueger As Chief Operating Officer

Endeavor Appoints Chris Krueger As Chief Operating Officer
BUSINESSWIRE
16 Apr 2024
Share Share
Endeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. as President

Endeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. as President
BUSINESSWIRE
14 Mar 2024
Share Share
Endeavor BioMedicines Successfully Completes Phase 2a Trial of ENV-101

Endeavor BioMedicines Successfully Completes Phase 2a Trial of ENV-101
BUSINESSWIRE
24 Jan 2024
Share Share
Endeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. to Board of Directors

Endeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. to Board of Directors
BUSINESSWIRE
19 Dec 2023
Share Share
Endeavor signs $430M deal for Hummingbird’s HER3-targeted ADC

Endeavor signs $430M deal for Hummingbird’s HER3-targeted ADC
FIERCE BIOTECH
20 Oct 2023
Share Share
Endeavor BioMedicines Completes Enrollment in Phase 2a Clinical Trial of ENV-101

Endeavor BioMedicines Completes Enrollment in Phase 2a Clinical Trial of ENV-101
BUSINESSWIRE
06 Sep 2023
Share Share